Theriva Biologics, Inc. Proceeds from Issuance of Warrants
Theriva Biologics, Inc. (TOVX) reported Proceeds from Issuance of Warrants of $8.00 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2022-03-16
- Theriva Biologics, Inc. proceeds from issuance of warrants for the quarter ending 2012-09-30 was $100.00K.
- Theriva Biologics, Inc. proceeds from issuance of warrants for fiscal 2021 was $8.00M.
- Theriva Biologics, Inc. proceeds from issuance of warrants for fiscal 2011 was $15.00K.
| Period end | Proceeds from Issuance of Warrants 0 month | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | $8.00M 10-K · filed 2022-03-16 | ||||
| 2012-09-30 | $100.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $2.00M 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | $1.90M 10-Q/A · filed 2012-09-11 | ||||
| 2011-12-31 | $15.00K 10-K · filed 2013-04-16 | ||||
| 2011-04-06 | $3.50M 10-K · filed 2013-04-16 | ||||
| 2011-01-28 | $4.00M 10-K · filed 2013-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |